These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38661023)
1. Prurigo nodularis: A "Cinderella" disease with significant burden and a bright future. Yosipovitch G J Eur Acad Dermatol Venereol; 2024 May; 38(5):790-791. PubMed ID: 38661023 [No Abstract] [Full Text] [Related]
2. Treatment and Burden of Disease in a Cohort of Patients with Prurigo Nodularis: A Survey-based Study. Todberg T; Zachariae C; Skov L Acta Derm Venereol; 2020 Apr; 100(8):adv00119. PubMed ID: 32215661 [TBL] [Abstract][Full Text] [Related]
3. A Nationwide Study of Prurigo Nodularis: Disease Burden and Healthcare Utilization in the United States. Wongvibulsin S; Sutaria N; Williams KA; Huang AH; Choi J; Roh YS; Hong M; Kelley D; Pahalyants V; Murphy W; Alphonse MP; Bakhshi P; Walia A; Semenov YR; Kwatra SG J Invest Dermatol; 2021 Oct; 141(10):2530-2533.e1. PubMed ID: 33823182 [No Abstract] [Full Text] [Related]
6. Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Ständer S; Ketz M; Kossack N; Akumo D; Pignot M; Gabriel S; Chavda R Acta Derm Venereol; 2020 Nov; 100(18):adv00309. PubMed ID: 33021323 [TBL] [Abstract][Full Text] [Related]
7. Impact of Chronic Kidney Disease Severity on the Risk of Prurigo Nodularis: A Population-Based Cohort Study. Kim HS; Kim HJ; Ahn HS Acta Derm Venereol; 2022 Sep; 102():adv00781. PubMed ID: 35971831 [TBL] [Abstract][Full Text] [Related]
8. Disease burden and treatment satisfaction in patients with prurigo nodularis in Japan. Murota H; Arima K; Yoshida T; Fujita H J Dermatol; 2024 Feb; 51(2):223-233. PubMed ID: 38066728 [TBL] [Abstract][Full Text] [Related]
9. Treatment of idiopathic prurigo nodularis in Taiwanese patients with low-dose thalidomide. Lan CC; Lin CL; Wu CS; Chai CY; Chen WT; Chen GS J Dermatol; 2007 Apr; 34(4):237-42. PubMed ID: 17352720 [TBL] [Abstract][Full Text] [Related]
10. Prurigo nodularis: a review. Lee MR; Shumack S Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418 [TBL] [Abstract][Full Text] [Related]
11. Prurigo nodularis: Pathogenesis and management. Williams KA; Huang AH; Belzberg M; Kwatra SG J Am Acad Dermatol; 2020 Dec; 83(6):1567-1575. PubMed ID: 32461078 [TBL] [Abstract][Full Text] [Related]
12. Tofacitinib for Prurigo Nodularis: A Case Report. Peng C; Li C; Zhou Y; Wang Q; Xie P; Li T; Hao P Clin Cosmet Investig Dermatol; 2022; 15():503-506. PubMed ID: 35340735 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of Prurigo Nodularis in Poland. Ryczek A; Reich A Acta Derm Venereol; 2020 May; 100(10):adv00155. PubMed ID: 32421199 [TBL] [Abstract][Full Text] [Related]
14. Histopathological and bacteriological findings in prurigo nodularis. Mattila JO; Vornanen M; Katila ML Acta Derm Venereol; 1997 Jan; 77(1):49-51. PubMed ID: 9059678 [TBL] [Abstract][Full Text] [Related]